| Literature DB >> 35839214 |
Alice Bellicha1,2,3, Cecile Ciangura1, Celina Roda4,5, Adriana Torcivia6, Judith Aron-Wisnewsky1,2, Christine Poitou1,2, Jean-Michel Oppert1,3.
Abstract
BACKGROUND AND OBJECTIVES: We previously showed in a 6-month randomized controlled trial that resistance training and protein supplementation after bariatric surgery (Roux-en-Y gastric bypass, RYGB) improved muscle strength without significant effect on weight loss and body composition changes. We performed a 5-year follow-up study in these subjects with the aim 1) to assess the long-term effect of this exercise training intervention and 2) to analyze associations between habitual physical activity (PA) and weight regain at 5 years.Entities:
Mesh:
Year: 2022 PMID: 35839214 PMCID: PMC9286216 DOI: 10.1371/journal.pone.0271561
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1Flow chart of the follow-up study.
Characteristics of patients before and 5 years after RYGB (whole sample with intervention groups combined, N = 54).
| N | Before RYGB | N | 5 years after RYGB | |
|---|---|---|---|---|
| Age, years | 54 | 43.5 (9.9) | 54 | 49.4 (9.8) |
|
| ||||
| Body weight, kg | 54 | 117.2 (15.7) | 54 | 84.4 (14.8) |
| BMI, kg/m2 | 54 | 44.2 (5.4) | 54 | 31.9 (5.6) |
| Body fat, % | 53 | 49.9 (3.8) | 53 | 42.8 (5.4) |
| LBM, kg | 53 | 55.8 (6.7) | 53 | 46.2 (5.7) |
|
| 54 | 54 | ||
| Type 2 diabetes, N (%) | 17 (31.5%) | 9 (16.7%) | ||
| Sleep apnea syndrome, N (%) | 31 (57.4%) | 5 (9.3%) | ||
| Hypertension, N (%) | 18 (33.3%) | 10 (18.5%) | ||
|
| ||||
| Handgrip strength, kgF | 54 | 31.1 (7.0) | 43 | 31.5 (4.9) |
| Leg-press 1-RM | ||||
| Absolute, kg | 53 | 182.6 (51.7) | 40 | 129.1 (40.7) |
| Relative to body weight, kg/kg | 53 | 1.57 (0.47) | 1.53 (0.36) | |
| VO2peak | ||||
| Absolute, L/min | 51 | 2.1 (0.5) | 37 | 1.64 (0.59) |
| Relative to body weight, mL/min/kg | 51 | 18.2 (4.3) | 37 | 19.5 (6.5) |
|
| 50 | 48 | ||
| Accelerometer wear time, min/d | 798 (737;847) | 804 (762; 877) | ||
| Counts per minute | 292 (229;368) | 308 (253;378) | ||
| Sedentary time, min/d | 486 (434;538) | 498 (439;554) | ||
| Total PA, min/d | 303 (256;378) | 302 (252;383) | ||
| Light-intensity PA, min/d | 267 (228;344) | 265 (226;360) | ||
| Moderate-intensity PA, min/d | 24.7 (15.6;35.9) | 29.1 (19.3;39.3) | ||
| Vigorous-intensity PA, min/d | 0.0 (0.0;0.0) | 0.0 (0.0;0.1) | ||
| MVPA, min/d | 24.7 (15.6;36.0) | 29.1 (19.5;40.0) | ||
| MVPA spent in bouts, min/week | 25.0 (0.0;84.8) | 47.5 (0.0;133.0) | ||
| MVPA bouts, n/d | 0.3 (0.0;0.8) | 0.4 (0.0;6.1) | ||
| Proportion of total MVPA spent in bouts, % | 10.9 (0.0;26.4) | 12.4 (0.0;30.8) | ||
| Meet PA guidelines, N (%) | 30 (60.0%) | 33 (68.8%) | ||
|
| NA | 49 | ||
| Leisure-time sedentary behavior, min/d | NA | 234 (168;330) | ||
| TV time, min/d | NA | 126 (90;150) | ||
| Leisure-time moderate-intensity PA, min/d | NA | 13.9 (0.0;32.7) | ||
| Leisure-time vigorous-intensity PA, min/d | NA | 0.0 (0.0;3.0) | ||
| Leisure-time MVPA, min/d | NA | 16.6 (0.0;46.1) | ||
| Transport-related PA (walking and cycling) | NA | 14.3 (2.1;34.3) | ||
| Total MVPA, min/d | NA | 40.9 (18.8;66.4) | ||
| Meet PA guidelines, N (%) | NA | 35 (71.4%) |
Data are frequencies (percentages) or means (standard deviations) or medians (25th and 75th percentiles).
Abbreviations. 1-RM, one repetition maximum; BMI, body mass index; LBM, lean body mass; MVPA, moderate-to-vigorous physical activity; TV, television.
Changes in body composition, physical fitness, habitual physical activity and nutritional status 5 years after RYGB.
| Change from baseline (95% CI) | P-value | ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
| Group | Time | Group by time | |
|
| |||||||
| Body weight, kg | 54 | -32.1 (-35.5;-28.8) | -32.4 (-35.3;-29.4) | -34.0 (-37.6;-30.5) | 0.503 |
| 0.991 |
| BMI, kg/m2 | 54 | -12.1 (-13.3;-10.9) | -12.0 (-13.1;-11.0) | -13.0 (-14.3;-11.7) | 0.233 |
| 0.969 |
| Fat mass, kg | 54 | -22.1 (-24.8;-19.3) | -21.0 (-23.5;-18.5) | -23.8 (-26.8;-20.8) | 0.160 |
| 0.854 |
| Lean body mass, kg | 54 | -10.0 (-11.4;-8.6) | -9.8 (-11.0;-8.5) | -9.1 (-10.6;-7.5) | 0.987 |
| 0.964 |
|
| |||||||
| Handgrip, kgF | 54 | 0.9 (-1.8;3.5) | -1.0 (-3.3;1.4) | 3.1 (-0.2;6.3) | 0.127 |
| 0.342 |
| Leg-press 1-RM | |||||||
| Absolute, kg | 51 | -49.9 (-81.0;-18.8) | -44.4 (-71.5;-17;3) | -55.5 (-90.1;-20.9) |
|
| 0.806 |
| Relative to body weight, kg/kg | 51 | -0.1 (-0.4;0.2) | 0.1 (-0.2;0.3) | 0.1 (-0.3;0.3) | 0.192 |
| 0.589 |
| Relative to lower limb LBM, kg/kgLBM | 51 | -1.4 (-3.1;0.4) | -0.7 (-2.2;0.9) | -0.9 (-2.9;1.0) | 0.348 |
| 0.618 |
|
| |||||||
| VO2 peak | |||||||
| Absolute, L/min | 53 | -0.4 (-0.7;-0.2) | -0.4 (-0.7; -0.2) | -0.4 (-0.7;-0.1) | 0.425 |
| 0.627 |
| Relative to body weight, mL/min/kg | 53 | 0.8 (-2.3;4.0) | 2.5 (-0.4;5.3) | 1.5 (-1.9;4.9) | 0.203 |
| 0.784 |
| Relative to LBM, mL/min/kgLBM | 53 | -2.8 (-8.6;3.0) | -1.0 (-6.2;4.3) | -2.1 (-8.5;4.2) | 0.432 | 0.364 | 0.737 |
|
| |||||||
| Wear time, min/d | 52 | 16.3 (-30.5;63.1) | 38.0 (-3.4;79.4) | 48.2 (-4.5;100.9) | 0.596 |
| 0.629 |
| Sedentary time, min/d | 52 | 20.5 (-24.0;65.0) | 34.2 (-5.2;73.7) | 17.6 (-32.5;67.6) |
| 0.058 | 0.853 |
| Counts per minute | 52 | -8.3 (-69.0;52.5) | 15.3 (-38.8;69.3) | 54.2 (-14.2;122.6) | 0.145 | 0.270 | 0.483 |
| Light-intensity PA, min/d | 52 | -5.1 (-41.7;31.5) | -0.4 (-32.9;32.1) | 18.3 (-22.9;59.5) | 0.325 | 0.614 | 0.303 |
| MVPA, min/d | 52 | 0.1 (-10.0;10.1) | 3.1 (-5.8;12.1) | 12.4 (1.1;23.8) | 0.303 | 0.059 | 0.353 |
| MVPA in ≥10-min bouts, min/wk | 52 | 13.8 (-45.7;73.4) | 23.7 (-29.3;76.7) | 44.7 (-22.3;111.7) | 0.263 | 0.160 | 0.745 |
|
| |||||||
| Hemoglobin, g/dL | 54 | -0.2 (-0.7;0.2) | -0.2 (-0.6; 0.2) | -0.4 (-0.9;0.1) | 0.346 |
| 0.975 |
| Proteinemia, g/L | 54 | -4.4 (-6.4;-2.4) | -2.8 (-4.6;-1.0) | -2.2 (-4.4;-0.4) | 0.483 |
| 0.726 |
| Albumin, g/L | 54 | 4.6 (3.0;6.3) | 5.4 (3.9;6.8) | 5.3 (3.6;7.1) | 0.367 |
| 0.967 |
| Prealbumin, g/L | 54 | -0.02 (-0.04;-0.01) | -0.01 (-0.02;0.01) | -0.02 (-0.04;-0.01) | 0.637 |
| 0.781 |
| 25(OH) Vitamin D3, ng/mL | 54 | 11.1 (5.4;16.8) | 8.9 (3.9;14.0) | 11.9 (5.9;17.8) | 0.855 |
| 0.970 |
| Thiamine, nmol/L | 54 | 50.7 (17.9;83.4) | 22.6 (-4.9;50.1) | 35.5 (2.3;68.6) | 0.600 |
| 0.339 |
| Erythrocyte folate, nmol/L | 54 | 512.1 (280.4;743.8) | 676.6 (474,5;878.6) | 924.7 (664.1;1185.3) | 0.209 |
| 0.244 |
| B12, pmol/L | 54 | -173.3 (-238.9;-107.7) | -123.5 (-182.9;-64.2) | -129.5 (-200.9;-58.1) | 0.856 |
| 0.820 |
P-values for group, time, and interaction (group × time) terms in mixed models; bold values indicate significance with P < 0.05.
1-RM, one-repetition maximum; CON, control group; PRO, protein intake group; PRO+EX, protein intake and supervised strength training group; LBM, lean body mass; MVPA, moderate-to-vigorous physical activity; PA, physical activity.
Fig 2Associations between weight regain 5 years after RYGB and changes in PA outcomes.
Data are medians (25th and 75th percentiles). a Non-adjusted P-value from Wilcoxon rank sum test. b Logistic regression with accelerometer wear time and baseline preoperative data as covariables (only for accelerometry data). Odds-ratios represent the association between an interquartile range (IQR) increase in PA levels and weight regain (<10% vs. ≥10%). Error bars represent the 95% confidence interval of the OR. Bold values indicate significance with P < 0.05. Self-reported total MVPA is calculated as the sum of leisure-time MVPA and transport-related walking and cycling. Abbreviations: MVPA, moderate-to-vigorous PA.
Fig 3Type and duration of leisure-time activities performed 5 years after RYGB.
Jogging, indoor aerobic exercise, climbing were reported by one or two patients and are therefore not presented in this figure.